Beyond CHD, genetically lowered Lp(a) levels are associated with lower risks of peripheral vascular disease, stroke, heart failure, and aortic stenosis (Emdin et al., 2016; Schnitzler et al., 2019). Here, LPA is linked to coronary artery disorder.